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http://dx.doi.org/10.1016/j.pedneo.2Background: The purpose of this study was to identify prognostic indicators of neurodevelop-
mental outcome in term infants who experienced clinical neonatal seizure.
Methods: This is a retrospective, observational hospital-based study. Term infants who ex-
perienced clinical neonatal seizure between January 1999 and December 2009 were enrolled.
Adverse outcomes were defined as death, cerebral palsy, global developmental delay, and/or
epilepsy. The associations between adverse outcomes and 17 variables, including sex, mode
of delivery, being small of gestational age, maternal illness, perinatal insults, meconium
stained liquor, Apgar score at 1 and 5 minutes, seizure onset age, seizure type, etiology, elec-
troencephalography (EEG) findings, antiepileptic drug efficacy, presence of metabolic acido-
sis, and cranial ultrasonographic findings, and presence of congenital heart disease were
analyzed.
Results: Among the 232 enrolled infants, 125 had a normal outcome and 14 had mild
functional disability (59.9%), and 55 (23.7%) survived with one or more neurodevelopmen-
tal impairments (7 with cerebral palsy, 48 with global developmental delay), and 38
(16.4%) died. Forty-seven (23.0%) of the 204 patients who survived after the first discharge
had epilepsy. Ten variables were associated with adverse outcome on univariate analysis,
but only four variables, i.e., including abnormal cranial ultrasonography findings, abnormal
anterior cerebral artery resistance index, abnormal EEG findings, and presence of conge-
nital heart disease were independent predictors on multivariate logistic regression analy-
sis.of Pediatrics, Mackay Memorial Hospital, 92, Chungshan North Road, Section 2, Taipei 10449, Taiwan.
h.org.tw (C.-S. Ho).
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Neonatal seizures 167Conclusion: In term infants with neonatal seizures, several risk factors related to adverse
outcome were recognized. Physicians should pay more attention to these factors when
handling patients with neonatal seizures.
Copyright ª 2013, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All
rights reserved.1. Introduction
Seizures are the most common and distinctive clinical
manifestation of neurologic dysfunction in the newborn
infants, and they may cause injury and exacerbate existing
brain damage.1,2 The incidence of seizures is higher in the
neonatal period than in any other period of life and is
estimated at approximately three per 1000 live births.1,3 To
date, the long-term neurodevelopmental outcome of chil-
dren with neonatal seizures is still unclear. Early inter-
vention for infants at risk for developmental disorders has
gained wide acceptance in the last few decades due to its
efficacy.
Several prognostic factors are well known, such as brain
maturity (preterm vs. term), neonatal electro-
encephalography (EEG) background patterns, cranial ultra-
sonography, Apgar score, birth weight, onset of seizures or
prolonged seizures.3e6 Garfinkle et al7 devised a 5-point
scoring system in term infant seizure using variables of de-
livery, seizure onset age, seizure type, EEG background find-
ings, and someetiology. Recognizing prognostic factors would
be helpful for neonatal seizure patients. This retrospective
study described the prognosis and searched for possible risk
factors of full-term newborns with neonatal seizures.2. Materials and Methods
The study population was derived from a single medical
center between January 1999 andDecember 2009. This study
was approved by the Institutional Review Boards of Mackay
Memorial Hospital in Taipei, Taiwan. The medical records of
all patients who were born at term (i.e., 37 weeks ges-
tation) and had clinically evident neonatal seizures (i.e.,
within the first 28 days of life) were retrospectively
reviewed. The diagnosis of clinical neonatal seizures was
made by a pediatric neurologist and neonatologist using
internationally accepted criteria.1 All patients had at least 2
years of neurologic follow-up data, or at least 1 year if the
infant was normal. Our study population consisted of 334
term infants, of whom 232 neonates (69%) met the inclusion
criteria. Data collected included sex, mode of delivery,
being small of gestational age, maternal illness, perinatal
insults, meconium stained liquor, Apgar score at 1 and 5
minutes, seizure onset age, seizure type, etiology, EEG
findings, antiepileptic drugs efficacy, presence of metabolic
acidosis, cranial ultrasonography findings, and presence of
congenital heart disease.
Maternal illness included hepatitis B carrier, drug
abuser, vaginal group B streptococcus colonization, pre-
mature rupture of membranes, antepartum hemorrhage,
placenta malfunctions, and systemic disease (i.e., hyper-
tension, pre-eclampsia, thyroid disorders). Perinatal insultsincluded fetal distress, delayed initial crying, need for
resuscitation in labor room, prolonged labor course,
abruptio placentae, cord around neck, and precipitating
labor. The seizure onset age was divided to before and after
24 hours of life. Seizure types were categorized according
to Volpe classification schema,1 based on the paroxysmal
clinical phenomena documented in the medical records. It
included subtle, clonic, tonic, myoclonic, and mixed-type
presentations.
The primary etiology of the seizure was determined
through the clinical history, neuroimaging studies [com-
puted tomography (CT), cranial ultrasonography findings,
and/or magnetic resonance imaging (MRI)], and laboratory
tests (cerebrospinal fluid studies, serum glucose and elec-
trolyte levels, blood gas analysis, lactate, pyruvate, alanine
transaminase, and creatine kinase). Some infants under-
went Toxoplasmosis gondii, rubella, cytomegalovirus, and
herpes simplex virus (TORCH) screen for congenital infec-
tion or workup for inborn error of metabolism. We divided
etiology into nine groups: (1) intrapartum asphyxia, (2)
metabolic disturbances (i.e., hypoglycemia, hypocalcemia,
hyponatremia, hypomagnesemia), (3) infections, (4) intra-
cranial hemorrhage, (5) cerebral infarct, (6) developmental
cerebral defect, (7) inborn error of metabolism (i.e., iso-
valeric acidemia, tyrosinemia type 1, maple syrup urine
disease), (8) miscellaneous (e.g., genetic disorder, neo-
natal abstinence syndrome), and (9) etiology unknown.
Intrapartum asphyxia required 5-minute Apgar score of 6
and fetal distress. The diagnosis of infection (bacterial or
viral) had confirmatory laboratory evidence on CSF or blood
culture. Intracranial hemorrhage included epidural, sub-
arachnoid, subdural, parenchymal, and/or intraventricular
hemorrhage. In cases in which this comprehensive diag-
nostic evaluation revealed no etiology, infants were
assigned to an “etiology unknown” category.
Interictal EEG recordings (international 10e20 system,
modified) were performed in tolerated neonates (Medelec,
Oxford, England). EEG analyses were performed by the
neurophysiologists, with respect to background pattern and
seizure activity, based on visual pattern recognition. EEG
findings were grouped into two categories: (1) normal and
(2) epileptiform activity or abnormal background activity.
Almost all infants had serial cranial ultrasonography
examinations. Some had at least one additional modality of
imaging, such as cranial CT or MRI. Cranial ultrasonography
findings were grouped into two categories: (1) normal and
(2) abnormal (i.e., parenchymal echodensities, hemor-
rhage, subependymal and choroid plexus cysts, ventricular
dilatation, brain malformations). We defined normal range
of anterior cerebral artery resistance index as 0.6e0.8
using the Acuson Aspen (Acuson Corp., Mountain View, CA,
USA) from 1999e2005 and the Voluson 730 Pro system from
2005e2009 (GE Medical Systems, Milwaukee, WI, USA).
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20e40 mg/kg and a maintenance dose of 3e8 mg/kg/day
intramuscular administered. If the seizures persisted or
recurred, then we administered phenytoin at a loading dose
of 20 mg/kg and a maintenance dose of 4e8 mg/kg/day
intravenously or midazolam loading dose of 0.1 mg/kg
intravenously followed by a continuous intravenous infusion
at 1e10 mg/kg/min. The presence of metabolic acidosis was
defined as pH < 7.35, HCO3 < 18 mEq/L, and need of
NaHCO3 supplement.
The neurologic outcome recorded at the last follow-up
was included in the subsequent data analysis. Outcomes
were defined as follows:
1. Normal and mild neurologic abnormalities (i.e., slow for
age in regard to motor and/or speech, hearing impair-
ment, mild mental retardation).
2. Cerebral palsy was defined as a static, nonprogressive
motor impairment of early onset featuring objective
changes in tone, muscle strength, posture, abnormal
deep tendon reflexes, and motor skills on examination.
Neuromotor assessment was based on Levine clinical
criteria.8 Motor skills were compared with those
expected for age.
3. Global developmental delay was defined as significant
delay in two or more developmental domains: gross or
fine motor, speech and language, cognition, personal-
social, and activity of daily living.
4. Epilepsy was defined as recurrent unprovoked seizures
that required antiepileptic drugs.
5. We divided the above-mentioned four categories into
two groups: “good outcome” (normal and mild neuro-
logical abnormalities) and “adverse outcome” (death,
cerebral palsy, and global developmental delay).Figure 1 Distribution of patient numbers in those with
cerebral palsy (CP), global development delay (GDD), and
epilepsy among survivors.2.1. Statistical analysis
Overall outcomes (i.e., good vs. adverse) were compared
with regard to sex, mode of delivery, being small of ges-
tational age, maternal illness, perinatal insults, meconium
stained liquor, Apgar score at 1 and 5 minutes, seizure
onset age, seizure type, etiology, EEG findings, anti-
epileptic drugs efficacy, presence of metabolic acidosis,
cranial ultrasonography findings, and presence of con-
genital heart disease. Statistical analyses were performed
by using SPSS 18.0 for windows (SPSS Inc, Chicago, IL, USA).
We used the c2 test and Fisher exact test for categorized
data. A p value of <0.05 was considered statistical signifi-
cant. Simple and multiple logistic regression models were
applied to determine risk factors for adverse neuro-
developmental outcome.
3. Results
The retrospective cohort for analysis included 232 infants,
comprising 139 males and 93 females. One hundred and
thirty-three infants were born by vaginal delivery (57.3%)
and 99 by cesarean delivery (42.7%). The mean birth
weight was 3112.8  548.6 g (1576e5020 g) and mean
gestational age was 38.9  1.2 weeks (37e42 weeks).Seventy-eight infants (33.6%) were born at the Mackay
Memorial Hospital. The remaining 154 infants were refer-
red from surrounding local community hospital or obstet-
rical clinics. One hundred and seventy-six (75.9%) interictal
EEG and 228 (98.3%) cranial ultrasonography examinations
were performed during hospitalization. Median follow-up
age for normal survivors was 3.3  3.1 years (minimum of 1
year), and, for abnormal survivors, it was 3.9  3.0 years
(minimum of 2 years).
Of the 232 children, 125 had a normal outcome and 14
had mild functional disability (total 59.9%), 55 (23.7%)
survived with a neurodevelopmental impairments, while 38
(16.4%) died. Seven abnormal survivors (3.6%) had cerebral
palsy. Forty-eight (24.7%) had global developmental delay.
Figure 1 illustrates the overlapping distribution of these
adverse outcomes. The median age of death for the 10
fatalities was 26.8  18.6 months (7e60 months).
Intrapartum asphyxia was the most common etiology
noted and was identified in 73 children (31.5%). Second
most common were metabolic disturbances diagnosed in 53
children (22.8%), followed by unknown etiology in 30
(12.9%). The most common cause of death was intrapartum
asphyxia (26.0%), although 41.4% infants with intrapartum
asphyxia had normal neurodevelopment. For those with
known etiology, metabolic disturbances and infections had
more favorable outcome (86.8%, 77.8%). Patients with un-
known etiology also had a relatively favorable outcome
(86.7%; Table 1).
Forty-seven (23.0%) of 204 patients who survived after
the first discharge had epilepsy. Thirty-eight patients
(80.9%) with epilepsy had adverse outcome, and nine
(19.1%) patients had normal outcome. Of the 194 survivors,
35 (18.0%) received antiepileptic drugs for less than 3
months, 29 (14.9%) for 3e6 months, 34 (17.5%) for 0.5e2
years, and 36 (18.5%) for more than 2 years.
Presence of perinatal insults, Apgar score at 1 minute,
time of seizure onset less 24 hours, metabolic acidosis,
abnormal EEG findings, presence of congenital heart dis-
ease, abnormal cranial ultrasonography findings, and
abnormal anterior cerebral artery resistance index were
the most significant risk factors in univariate analysis
Table 1 Outcomes of 232 neonatal seizure patients by primary etiologies and predominant seizure types.
n (%) Overall outcome, n (%) Abnormal outcome, n (%)
Normal Abnormal Dead CP GDD Epilepsy
Etiology 232 (100.0) 139 (59.9) 55 (23.7) 38 (16.4) 7 (12.7) 48 (87.3) 47 (23.0)*
Intrapartum asphyxia 73 (31.5) 30 (41.4) 24 (32.6) 19 (26.0) 7 (100) 17 (35.4) 16 (34)
Metabolic disturbances 53 (22.8) 46 (86.8) 4 (7.5) 3 (5.7) 0 4 (8.4) 6 (12.8)
Infections 18 (7.8) 14 (77.8) 3 (16.6) 1 (5.6) 0 3 (6.2) 2 (4.2)
Intracranial hemorrhage 15 (6.5) 9 (60.0) 4 (26.7) 2 (13.3) 0 4 (8.4) 2 (4.2)
Cerebral infarcts 7 (3.0) 2 (28.6) 5 (71.4) 0 0 5 (10.4) 3 (6.5)
Developmental cerebral defects 9 (3.9) 3 (33.3) 2 (22.2) 4 (44.5) 0 2 (4.1) 4 (8.5)
Inborn error of metabolism 14 (6.0) 5 (35.7) 6 (42.9) 3 (21.4) 0 6 (12.5) 7 (14.9)
Miscellaneous 13 (5.6) 4 (30.8) 3 (23.0) 6 (46.2) 0 3 (6.2) 2 (4.2)
Unknown 30 (12.9) 26 (86.7) 4 (13.3) 0 0 4 (8.4) 5 (10.7)
Seizure type
Subtle 102 (44.0) 57 (55.9) 24 (23.5) 21 (20.6) 4 (23.5) 20 (41.7) 19 (40.4)
Clonic 45 (19.4) 30 (66.7) 6 (13.3) 9 (20.0) 10 (58.8) 6 (12.5) 7 (14.9)
Tonic 32 (13.8) 17 (53.2) 11 (34.3) 4 (12.5) 1 (5.9) 10 (20.8) 8 (17.0)
Myoclonic 20 (8.6) 13 (65.0) 4 (20.0) 3 (15.0) 1 (5.9) 3 (6.2) 8 (17.0)
Mixed 33 (14.2) 22 (66.7) 10 (30.3) 1 (3.0) 1 (5.9) 9 (18.8) 5 (10.7)
* Percentage of 204 survivals.
CP Z cerebral palsy; GDD Z global developmental delay.
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Table 2.
The 1-minute Apgar score was 3 for 39 infants (16.8%)
and from 4e6 for 34 infants (14.7%). The 5-minute Apgar
score was 3 for 13 infants (5.6%) and from 4e6 for 31 in-
fants (13.4%). Only the 1-minute Apgar score was sig-
nificantly associated with an adverse outcome (p < 0.001).
Time of seizure onset appeared within 24 hours in 75
infants (32.3%). Sixty-two infants (26.7%) developed sei-
zures from 24e72 hours, 43 infants (18.5%) from 3e7 days,
and 52 infants (22.4%) developed seizures after 7 days of
life. Seizure type is presented in Table 1. Subtle seizures
were the most common type and constituted 44% of all
seizures. This type also had a higher relationship with
epilepsy (40.4%). The association of outcome and seizure
type did not differ significantly. One hundred and twenty-
seven infants (54.7%) required phenobarbital mono-
therapy to achieve clinical seizure control. Additional
antiepileptic drugs were administered to 91 infants
(39.2%) in whom seizure control was not achieved with
phenobarbital alone [phenytoin (42), benzodiazepine (10),
or both (39)].
Four poor outcome predictors were found by multiple
logistic regression. These were abnormal cranial ultraso-
nography findings, abnormal anterior cerebral artery
resistance index, abnormal EEG findings, and presence of
congenital heart disease (Table 3).4. Discussion
Previous studies on neonatal seizures reported comparable
percentages of surviving children with normal outcomes
(35e54%), and severely abnormal outcomes (28%) to our
results.1,4,9 Term infants who experienced seizures are
more likely to have a normal outcome than preterm in-
fants.4,5,10 Most experimental data demonstrate significantlong-term adverse consequences of seizures, including
permanent impairments in learning, memory, and
cognition.11,12
EEG background findings and neuroimaging (CT/MRI)
were documented as predictors in neonatal seizures of
term infants, which is compatible with our results.4,6,7,13
Although some abnormalities are better detected by MRI
techniques, cranial ultrasonography is sensitive enough to
identify most abnormalities that are known to be asso-
ciated with adverse neurologic outcome.14,15 Cranial ul-
trasonography is cost-efficient and noninvasive, and its
prognostic value for later neurologic sequelae has already
been suggested by several studies.16,17 Bolyan et al18 found
that cerebral blood flow velocity increased during neonatal
seizures even during the interictal status. The increase in
cerebral blood flow velocity is most likely to be due to
excessive demand for glucose and oxygen, but it may still
be insufficient to meet the pathological demands. A study
by Archer et al19 established a relation between abnormally
low resistance index values of anterior cerebral artery and
adverse neurodevelopment outcome. Prolonged excessive
cerebral blood flow contributes to cerebral edema and
vasoparalysis with accompanying loss of autoregulatory
mechanism.18 In our studies, abnormal anterior cerebral
artery resistance index is a significantly poor prognostic
factor on multivariate analysis. There was no collinearity
between cranial ultrasonography and anterior cerebral ar-
tery resistance index.
Previously, the predictive values of amplitude-
integrated EEG background patterns have been demon-
strated in asphyxiated infants.20e22 Moreover, due to the
absence of video-EEG monitoring, the number of infants
with seizures in this cohort is probably underestimated.
Background EEG abnormalities of moderate to severe
grades were strong predictors of poor outcome in earlier
reports.23e26 Some also reported a correlation between
multifocal EEG abnormalities and outcome.27,28 Monod
Table 2 Outcome of neonatal seizures in different clinical conditions.
Variable Total, n Normal outcome, n (%) Adverse outcome, n (%) p
Perinatal insults
Absent 123 87 (70.7) 36 (29.3) <0.001
Present 109 52 (47.7) 57 (52.3)
Apgar score at 1 min
0e3 39 12 (30.8) 27 (69.2) <0.001
4e6 34 20 (58.8) 14 (41.2)
7e10 159 107 (67.3) 52 (32.7)
Apgar score at 5 min
0e3 13 0 13 (100.0) <0.001
4e6 31 11 (35.5) 20 (64.5)
7e10 188 128 (68.1) 60 (31.9)
Seizure onset
<24 h 75 32 (42.7) 43 (57.3) <0.001
>24 h 157 107 (68.2) 50 (31.8)
Anticonvulsant therapy efficacy
No medication 14 14 (100.0) 0 <0.001
Phenobarbital only 127 91 (71.7) 36 (28.3)
Additional AED required 91 34 (37.4) 57 (62.6)
Metabolic acidosis
Absent 152 104 (68.4) 48 (31.6) <0.001
Present 80 35 (43.8) 45 (56.2)
EEG findings
Normal 73 55 (75.3) 18 (24.7) 0.011
Abnormal 103 58 (56.3) 45 (43.7)
Congenital heart disease
Absent 201 127 (63.2) 74 (36.8) 0.011
Present 31 12 (38.7) 19 (61.3)
Cranial ultrasonography findings
Normal 52 44 (84.6) 8 (15.4) <0.001
Abnormal 176 92 (52.3) 84 (47.7)
Resistance index
0.6e0.8 138 99 (71.7) 39 (28.3) <0.001
<0.6 or >0.8 90 37 (41.4) 53 (58.9)
AED Z antiepileptic drugs; EEG Z electroencephalography.
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cohort (135 full-term babies); and they found that normal
EEG was prognostic for favorable outcomes (normal or
minor neurologic sequelae), and certain EEG patterns (e.g.,
inactive or paroxysmal EEG, low voltage with theta rhythm,
persistent absence of occipital activity, abnormal anterior
activity, fast spikes) were prognostically unfavorable. Ab-
normalities detected by brain imaging studies and number
of independent electrographic seizure foci were correlated
with some aspects of cognitive outcome.30 In our study, 90
neonates (51.1%) had interictal epileptiform activity, of
whom 35 had adverse outcomes and 29 had epilepsy; 13
(7.4%) had abnormal background activity, of whom 10 had
adverse outcomes and seven had epilepsy. Seventeen had
multifocal epileptiform activity in which 11 (64.7%) had
both adverse outcomes and epilepsy. Four had a burst-
suppression EEG pattern, all of whom had adverse out-
comes and epilepsy. Our data showed that abnormal
background and multifocal epileptiform activity were fre-
quently related to adverse outcome and that burst-
suppression EEG pattern had the worst outcome.The infants with complex congenital heart disease are at
high risk for seizures in the perioperative period.31 It is
obvious that convulsive states cause increased systemic and
cerebral metabolic activities, requiring increases in energy
supply. Congenital heart disease may exacerbate the en-
ergy imbalance and cause adverse outcome. It is also known
that cardiac dysfunction and diminished cardiac output are
late complications of seizures.1 In our studies, presence of
congenital heart disease distributes risk factors of adverse
outcome.
Some studies have suggested that the cause of neonatal
seizures is the most important factor in influencing out-
come.1,4,5,32,33 In particular, asphyxia and cerebral hem-
orrhage are related to poor outcome. Other etiologies
associated with poor outcome included cerebral dys-
genesis, global hypoxia-ischemia, and central nervous sys-
tem infection.4,34 However, we did not find a statistical
relationship between seizure etiology and outcome. We
think that the discrepancy may be explained by the dif-
ferences in study populations. Our population focused on
term infants. The number of infants with metabolic
Table 3 Predictors of adverse outcome in neonatal seizures in term infants.
Variable Univariate analysis Multivariate analysis
OR (95% CI) p OR (95%CI) p
Perinatal insults
Absent 1.000
Present 2.649 (1.543e4.548) <0.001 0.25
Apgar score at 1 min
7e10 1.000
4e6 1.44 (0.674e3.077) 0.346 0.59
0e3 4.630 (2.173e9.864) <0.001
Apgar score at 5 min
7e10 1.000
4e6 3.879 (1.748e8.607) 0.001
0e3 NA
Seizure onset
<24 hours 2.876 (1.630e5.072) <0.001 0.459
>24 hours 1.000
Anticonvulsant therapy efficacy
No medication 1.000
Phenobarbital only NA
Additional AED required NA
Acidosis
Absent 1.000
Present 2.786 (1.593e4.870) <0.001 0.642
EEG findings
Normal 1.000
Abnormal 2.371 (1.226e4.584) 0.01 3.466 (1.585e7.577) 0.002*
Congenital heart disease
Absent 1.000
Present 2.717 (1.249e5.913) 0.012 3.993 (1.104e14.443) 0.035*
Cranial ultrasonography findings
Normal 1.000
Abnormal 5.022 (2.236e11.281) <0.001 6.361 (1.688e23.968) 0.006*
Resistance index
0.6e0.8 1.000
<0.6 or >0.8 3.636 (2.077e6.366) <0.001 3.470 (1.576e7.639) 0.002*
*p < 0.05
AED Z antiepileptic drugs; CI Z confidence interval; EEG Z electroencephalography; OR Z odds ratio; NA Z not available.
Neonatal seizures 171disturbances was higher and intrapartum asphyxia was
lower than previous studies.
Heide et al35 found that persistent seizures, despite the
number of antiepileptic drugs required, are prognostic for
poor outcome. Prolonged or recurrent seizures are
thought to be associated with poor neurologic outcome in
other studies.30,32,36,37 Recurrent neonatal seizures also
result in subsequent alterations in seizure sus-
ceptibility.38e40 Several neurobiologic changes were
reported in infants with neonatal seizures, such as the
disruption of neuronal development, the induction of
synaptic reorganization, altered plasticity, molecular
reorganization of receptors and channels, and “priming”
the brain for increased damage from seizures in later life.
We did not find a relation between number of anti-
epileptic drugs and outcome. The outcome and seizure
type did not have significant association. Status epi-
lepticus, which may be a predictor of outcome, was not
recorded in our medical charts.5. Conclusion
We propose four variables of term infants with neonatal
seizures for providing early prognostic information on the
poor neurodevelopmental outcome: abnormal cranial ul-
trasonography findings, abnormal anterior cerebral artery
resistance index (<0.6 or >0.8), EEG epileptiform activity
or abnormal background activity, and presence of con-
genital heart disease.References
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